Evidence-Based Oncology > May

Evidence-Based Oncology – May

May 23, 2012 – Kim Farina, PhD
UPMC Oncologists: Pioneers in the Clinical Pathways Movement
May 23, 2012 – Jennifer Klemm, PhD; and Stanton R. Mehr
May 23, 2012 – Dawn G. Holcombe, MBA, FAMCPE, ACHE
May 24, 2012 – Keith Beagin
Signaling the Future of Personalized Medicine
May 24, 2012 – Jennifer Klemm, PhD; and Stanton R. Mehr
May 24, 2012 – Michael Kolodziej, MD; and J. Russell Hoverman, MD, PhD
Getting On Pathway?
May 24, 2012 – Anna Azvolinsky, PhD
Money Well Spent?
May 24, 2012 – Marjorie P. Zimmerman, MS, BSPharm, RPh; and Stanton R. Mehr
May 24, 2012 – Alice Goodman
SABCS Conference Coverage
May 24, 2012
This article was sponsored by Eisai Inc. The 2012 Eisai Oncology Digest was commissioned and funded by Eisai Inc.
May 24, 2012
Multiple Myeloma: Pre-Transplant Induction, Consolidation, and Maintenance Therapy
May 24, 2012 – Robert “Bo” Gamble
Getting Smarter in How We Score and Promote Value
May 24, 2012 – Michael Marlan Mohundro, PharmD; and Brice Labruzzo Mohundro, PharmD
Availability of Newer Agents May Lower Healthcare Costs
May 24, 2012
Interview With Allen S. Lichter, MD, Chief Executive Officer, American Society of Clinical Oncology
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome to the new and improved AJMC.com, the premier managed markets network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!